Leap Therapeutics Inc (LPTX) Event May 13, 2022, 00:00 UTC (76% Positive) LEAP THERAPEUTICS, INC. (LPTX) Reports Net Loss for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 8:56 a.m. 🏢 Leap Therapeutics Inc (LPTX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-13 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-9.13M $-10.38M $1.24M +11.97% 📉 Total Assets $117.91M $105.90M $12.01M +11.34% 📈 Total Liabilities $10.02M $7.34M $2.68M +36.49% 📉 Stockholders' Equity $98.56M $-273.95M $372.50M +135.98% 📈 Operating Income/Loss $-9.17M $-10.63M $1.46M +13.73% 📉 R&D Expense $6.81M $7.78M $-977.00K -12.55% 📈 Earningspersharebasic $-0.12 $-0.09 $-0.03 -33.33% 📉 Earningspersharediluted $-0.12 $-0.09 $-0.03 -33.33% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Leap Therapeutics Inc (LPTX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document